Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(20):1574-1575; doi:10.1093/jnci/93.20.1574
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Masters, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masters, J. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 20, 1574-1575, October 17, 2001
© 2001 Oxford University Press

CORRESPONDENCE

Re: Methods to Improve Efficacy of Intravesical Mitomycin C: Results of a Randomized Phase III Trial

John R. Masters

Correspondence to: John R. Masters, Ph.D., FRCPath., Institute of Urology, University College London, 3rd Floor, 67 Riding House St., London W1W 7EY, U.K. (e-mail: J.Masters@ucl.ac.uk)

It is remarkable that intravesical chemotherapy has been administered to patients with superficial bladder cancer for 40 years with so little research to optimize the many variables that could influence the response of the cancer. This failure has been due in part . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?